| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
143,149 |
123,361 |
$7.21M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
97,121 |
82,684 |
$4.49M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
51,386 |
45,419 |
$3.90M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
36,769 |
33,288 |
$2.94M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
31,000 |
27,624 |
$2.42M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
26,443 |
24,111 |
$1.95M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15,533 |
13,509 |
$1.30M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15,192 |
14,198 |
$715K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14,572 |
10,301 |
$633K |
| 92551 |
|
44,996 |
39,573 |
$413K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14,389 |
10,437 |
$275K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,513 |
4,511 |
$171K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
21,652 |
11,653 |
$157K |
| 99173 |
|
65,821 |
57,729 |
$127K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,146 |
3,619 |
$123K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,118 |
18,302 |
$108K |
| 96127 |
|
23,755 |
19,721 |
$102K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,903 |
5,346 |
$101K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
8,204 |
6,837 |
$93K |
| 99215 |
Prolong outpt/office vis |
881 |
798 |
$88K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,817 |
3,552 |
$70K |
| 96160 |
|
19,419 |
16,341 |
$62K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,867 |
5,916 |
$61K |
| 3008F |
|
69,984 |
60,878 |
$54K |
| 83655 |
|
5,540 |
4,790 |
$44K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
507 |
457 |
$23K |
| 99051 |
|
8,477 |
7,709 |
$23K |
| 99174 |
|
4,638 |
3,963 |
$22K |
| 87081 |
|
3,695 |
3,151 |
$17K |
| 99460 |
|
257 |
238 |
$16K |
| 82465 |
|
5,471 |
4,674 |
$15K |
| 87634 |
|
387 |
308 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
934 |
885 |
$8K |
| 99383 |
|
92 |
77 |
$6K |
| 99381 |
|
74 |
63 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
325 |
230 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
92 |
81 |
$4K |
| 85013 |
|
1,523 |
1,377 |
$4K |
| 96112 |
|
29 |
29 |
$3K |
| 90670 |
|
19,620 |
18,454 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
268 |
219 |
$2K |
| 90651 |
|
7,053 |
6,432 |
$2K |
| 96380 |
|
101 |
94 |
$2K |
| 90686 |
|
23,887 |
22,265 |
$2K |
| 99382 |
|
22 |
17 |
$2K |
| 90677 |
|
4,214 |
4,024 |
$1K |
| 82948 |
|
574 |
463 |
$1K |
| 90734 |
|
4,265 |
3,897 |
$1K |
| 90480 |
|
28 |
26 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
46 |
43 |
$918.89 |
| 99050 |
|
47 |
44 |
$761.93 |
| 90723 |
|
15,284 |
14,466 |
$650.83 |
| 71045 |
Radiologic examination, chest; single view |
36 |
34 |
$583.68 |
| 90716 |
|
9,131 |
8,330 |
$573.97 |
| 94760 |
|
2,145 |
1,674 |
$536.62 |
| 99462 |
|
14 |
13 |
$419.83 |
| 90672 |
|
46 |
40 |
$418.70 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
19 |
14 |
$377.13 |
| 81002 |
|
184 |
164 |
$345.39 |
| 90707 |
|
8,936 |
8,143 |
$312.50 |
| 81003 |
|
181 |
164 |
$302.88 |
| 90473 |
|
15 |
14 |
$258.06 |
| 90656 |
|
753 |
592 |
$234.39 |
| 90633 |
|
10,108 |
9,177 |
$163.52 |
| 90647 |
|
15,108 |
14,270 |
$136.82 |
| 90696 |
|
1,482 |
1,351 |
$61.83 |
| A7015 |
Aerosol mask, used with dme nebulizer |
138 |
101 |
$59.80 |
| 90461 |
|
49 |
29 |
$57.94 |
| 81025 |
|
23 |
12 |
$57.78 |
| 90715 |
|
1,429 |
1,296 |
$50.29 |
| 36416 |
|
322 |
301 |
$16.94 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
46 |
30 |
$0.83 |
| 90681 |
|
3,374 |
3,215 |
$0.00 |
| 90685 |
|
1,125 |
1,027 |
$0.00 |
| 90700 |
|
379 |
357 |
$0.00 |
| 90658 |
|
22 |
19 |
$0.00 |
| 90688 |
|
1,440 |
1,319 |
$0.00 |
| 99000 |
|
294 |
275 |
$0.00 |
| 1000F |
|
912 |
782 |
$0.00 |
| 90620 |
|
164 |
158 |
$0.00 |
| 91307 |
|
18 |
14 |
$0.00 |
| 90660 |
|
16 |
16 |
$0.00 |
| 90381 |
|
15 |
15 |
$0.00 |